DOI 10.1007/s12094-026-04342-4
Heterogeneity in primary gastrointestinal DLBCL: from clinical management to molecular mechanisms and treatment strategies.
Аннотация
Diffuse large B cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL), with approximately 30%-40% of cases occurring in extranodal organs. Primary gastrointestinal diffuse large B cell lymphoma (PGI-DLBCL) is a predominant subtype of extranodal lymphoma, accounting for 40%-50% of extranodal DLBCL cases. However, due to its location of onset in the gastrointestinal tract, it is different from cancer of epithelial or primary intranodal DLBCL or other extranodal DLBCL. The patients with PGI-DLBCL are often first diagnosed in the department of gastroenterology and gastrointestinal surgery. These patients are prone to develop bulky masses and lead to severe gastrointestinal complications. The heterogeneity of PGI-DLBCL is not only reflected in the differences in gene mutation profiles and tumor microenvironment but is also closely related to the diversity of clinical manifestations, varied treatment responses, and complex prognostic stratification. Currently, the clinicopathological characteristics and molecular genetics of these patients are not fully understood, which will lead to the clinical management difficulties and challenges. This review provides a relatively comprehensive analysis about the heterogeneity of PGI-DLBCL from four perspectives: aggressive growth features, pathological features, molecular genetic characteristics, and treatments.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.